SURG vs CHAI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 19, 2026

SURG

61.6
AI Score
VS
SURG Wins

CHAI

40.0
AI Score

Investment Advisor Scores

SURG

62score
Recommendation
BUY

CHAI

40score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SURG CHAI Winner
Revenue 56.96M 55.24M SURG
Net Income -36.07M -31.59M CHAI
Net Margin -63.3% -57.2% CHAI
Operating Income -34.14M -7.12M CHAI
ROE 235.0% -1018.5% SURG
ROA -423.6% -235.7% CHAI
Total Assets 8.52M 13.41M CHAI
Cash 1.73M 1.93M CHAI
Current Ratio 0.38 1.24 CHAI

Relative Price Performance (Last 90 Days)

SURG 1M: -8.6% · 3M: -60.2% CHAI 1M: +5.6% · 3M: -66.7%

Current Technical Phase

SURG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -30.4%), weak momentum, RSI 41

RSI (14): 41.1 · Price: $0.16

CHAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -38.3%), weak momentum, RSI 42

RSI (14): 41.7 · Price: $0.28

Fundamentals Snapshot

Metric SURG CHAI
Market Cap
Forward P/E 16.0 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.4% 0.6%
Gross Margin -0.2% -0.1%
Operating Margin 0.2% -0.1%
EPS -1.49 -0.62
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SURG is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.